http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2309745-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
| filingDate | 2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b10d512762dfdb9652841cf8aaa4e76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f4c35cd68bb708b84c3adc07125b6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665813080ace97bace240ca209e86c71 |
| publicationDate | 2007-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2309745-C2 |
| titleOfInvention | Medicinal agent offering anti-ischemic, antihypoxic and anticonvulsant effect in cranial trauma |
| abstract | FIELD: medicine, pharmacy. n SUBSTANCE: invention proposes using the known soporific and modulator of GABA activity zopiclone as a drug showing multifactor neuroprotective effect on ischemia, hypoxia with hypercapnia and convulsions in acute period of cranial trauma. Invention provides prophylaxis of secondary complications caused by cranial trauma and normalization of nervous-psychic status. It has shown that in first three days of post-traumatic period zopiclone increased resistance of brain in trauma to ischemia, hypoxia, hypercapnia and convulsions by 24.9-42.6% as compared with effect of nimodipine or antioxidant sodium hydroxybutyrate. n EFFECT: enhanced and valuable medicinal properties of drug. n 4 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2758433-C1 |
| priorityDate | 2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.